Cargando…
Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691905/ https://www.ncbi.nlm.nih.gov/pubmed/36424805 http://dx.doi.org/10.1002/ctm2.1122 |
| _version_ | 1784837135606480896 |
|---|---|
| author | Górecki, Dariusz C. |
| author_facet | Górecki, Dariusz C. |
| author_sort | Górecki, Dariusz C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9691905 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96919052022-11-28 Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD Górecki, Dariusz C. Clin Transl Med Commentary John Wiley and Sons Inc. 2022-11-24 /pmc/articles/PMC9691905/ /pubmed/36424805 http://dx.doi.org/10.1002/ctm2.1122 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentary Górecki, Dariusz C. Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD |
| title | Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD |
| title_full | Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD |
| title_fullStr | Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD |
| title_full_unstemmed | Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD |
| title_short | Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD |
| title_sort | dystrophin immunogenicity and requirement in myogenic cells: paradigm shift in gene therapy for dmd |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691905/ https://www.ncbi.nlm.nih.gov/pubmed/36424805 http://dx.doi.org/10.1002/ctm2.1122 |
| work_keys_str_mv | AT goreckidariuszc dystrophinimmunogenicityandrequirementinmyogeniccellsparadigmshiftingenetherapyfordmd |